Dr. Spector is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Lewis St
San Diego, CA 92103Phone+1 800-926-8273Fax+1 619-298-2698
Education & Training
- University of California (San Diego) Medical CenterFellowship, Infectious Disease, 1978 - 1981
- University of California (San Francisco)Residency, Pediatrics, 1975 - 1978
- Tufts University School of MedicineClass of 1975
Certifications & Licensure
- CA State Medical License 1976 - 2025
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Infectious Diseases
Awards, Honors, & Recognition
- Honored The Gertrude and Herman Silver Award from the Children’s, 2010
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Connect to Protect Partnerships for Youth Prevention Interventions: Phase II Start of enrollment: 2003 Sep 01
- Comparison of Three Hepatitis B Vaccination Regimens in HIV-Positive Youth Start of enrollment: 2004 Jan 01
- Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents Start of enrollment: 2009 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 6054 citationsEfficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.Lindsey R. Baden, Hana M. El Sahly, Brandon Essink, Karen L. Kotloff, Sharon E. Frey
The New England Journal of Medicine. 2021-02-04 - 1690 citationsGuidelines for the use and interpretation of assays for monitoring autophagy (4th edition)Daniel J. Klionsky, Amal Kamal Abdel-Aziz, Sara Abdelfatah, Mahmoud Abdellatif, Asghar Abdoli
Autophagy. 2021-02-08 - 128 citationsLocalization of human cytomegalovirus in peripheral blood leukocytes by in situ hybridization.Wayne M. Dankner, McCutchan Ja, Douglas D. Richman, Hirata K, Stephen A. Spector
The Journal of Infectious Diseases. 1990-01-01
Journal Articles
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 VaccineKaren Kotloff, Stephen A Spector, Carlos Fierro, The New England Journal of Medicine
- Human Immunodeficiency Virus Type-1 gp120 and Tat Induce Mitochondrial Fragmentation and Incomplete Mitophagy in Human NeuronsStephen Spector, MD, mBio
Press Mentions
- New Reassessments of How Clinical Trials Can and Should Be ConductedFebruary 3rd, 2023
- San Diego Toddler Enrolled in Pfizer COVID Vaccine TrialNovember 23rd, 2021
- Pfizer Seeks Emergency Use Authorization from FDA for Vaccine in Children 5 to 11 Years OldSeptember 21st, 2021
- Join now to see all
Grant Support
- Host Genetic Factors Associated With CNS Disease Of Hiv-Infected ChildrenNational Institute Of Neurological Disorders And Stroke2011–2012
- University Of California, SAN Diego Clinical Trial UnitNational Institute Of Allergy And Infectious Diseases2007–2012
- Clinical Trial: Impaact 1071National Center For Research Resources2010
- Clinical Trial: Antiretroviral Activity Of Raltegravir In HIV-1 Infected ChildreNational Center For Research Resources2010
- Vitamin D Inhibition Of HIV And M. Tuberculosis Coinfection In MacrophagesNational Institute Of Allergy And Infectious Diseases2009–2010
- Healthy Subject Cell CollectionNational Center For Research Resources2009–2010
- Adolescent Master Protocol (AMP) - Impact Of HIV And ART On GrowthNational Center For Research Resources2008–2010
- Clinical Trial: Pactg P1025 Pharmacokinetic Properties Of Antiretroviral DrugsNational Center For Research Resources2009
- CCTG 560a: Viral Population KineticsNational Center For Research Resources2009
- Clinical Trial: Pactg 1020a Novel Protease Inhibitor Bms-232632 In Children WithNational Center For Research Resources2008–2009
- Clinical Trial: Pactg P1025 Pharmacokinetic Properties Of Antiretroviral Drugs DNational Center For Research Resources2008
- Healthy Donor CellsNational Center For Research Resources2006–2008
- VirologyNational Institute Of Allergy And Infectious Diseases2007
- Pactg P1021 Emtricitabine And Efavirenz And Didanosine In HIVNational Center For Research Resources2007
- Pactg P1025 Pharmacokinetic Properties Of Antiretroviral Drugs During PregnancyNational Center For Research Resources2005–2007
- Pactg 1020a Novel Protease Inhibitor Bms-232632 In Children With HIVNational Center For Research Resources2005–2007
- Pactg P1039 Zidovudine/Lamivudine/Abacavir In Perinatal HIVNational Center For Research Resources2006
- Pediatric AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1988–2006
- Pactg P1052 Abacavir PK During Chronic Therapy In HIV InfectionNational Center For Research Resources2005
- Pactg P1022 Protease Inhibitor-Including/Sparing For HIV During PregnancyNational Center For Research Resources2005
- Normal Donor Cells For HIV AssaysNational Center For Research Resources2005
- ACTG 382 DMP 266 In Combination Wit Nelfinavir In Children With HIVNational Center For Research Resources2005
- Pediatric ACTG Coordinating And Operations CenterNational Institute Of Allergy And Infectious Diseases2002–2005
- Adolescent Medicine Trials Unit (AMTU)Eunice Kennedy Shriver National Institute Of Child Health &Human Development2002–2005
- Factors In Pediatric AIDS Transmission And PathogenesisNational Institute Of Allergy And Infectious Diseases2001–2005
- Protease Inhibitor Including Sparing For HIV PregnancyNational Center For Research Resources2004
- Pharmacokinetics Of Antiretrovirals During PregnancyNational Center For Research Resources2004
- Pactg P1021 Emtricitabine/Efavirenz/Didanosine In HIVNational Center For Research Resources2004
- Normal Donor CellsNational Center For Research Resources2004
- Actg382--Dmp 266 In Combination W/Nelfinavir In ChildrenNational Center For Research Resources2004
- Core -- Adolescent Medical TrialsNational Center On Minority Health And Health Disparities2002
- Ritonavir Therapy In HIV-1 Infected Infants And ChildrenNational Center For Research Resources2000–2002
- Comparison Of Combinations Of PI, Nrti, And NnrtiNational Center For Research Resources2000–2002
- ZDV &3tc &Nevirapine &Zdv &3tc &Nevirapine &1592u89 In HIV InfectionNational Center For Research Resources1999–2002
- Evaluation Of Ganciclovir For Congenital CytomegalovirusNational Center For Research Resources1999–2002
- Actg382--I592089 With Standard Zidovudine Therapy In NeonatesNational Center For Research Resources1999–2002
- Adolescent Medicine Trial Network For HIV/AIDSEunice Kennedy Shriver National Institute Of Child Health &Human Development2001
- Pediatric AIDS Clinical Trials Group--Coordinate/OperateNational Institute Of Allergy And Infectious Diseases1999–2001
- Core--Clinical Virology And Specimen BankingNational Institute Of Allergy And Infectious Diseases1998–2001
- ACTG 395 Indinavir W/ Stavudine &Lamivudine In Pediatric HIVNational Center For Research Resources1999
- ACTG 358--Oral Indinavir In HIV Pregnant Women &InfantsNational Center For Research Resources1999
- Actg330--1592u89 In Infants And Children With HIV InfectionNational Center For Research Resources1998–1999
- ACTG 250 Nevirapine In HIV-1 Pregnant Women And NeonatesNational Center For Research Resources1997–1999
- Hivig For The Prevention Of Maternal-Fetal HIV TransmissionNational Center For Research Resources1996–1999
- ACTG 300 Zidovudine VS DDI Monotherapy VS Didovudine PLUS DDI In HIV InfectionNational Center For Research Resources1996–1999
- ACTG 226 Oral Ganciclovir In HIV Infected Children With Cytomegalovirus InfectionNational Center For Research Resources1996–1999
- Pediatric Aids--Factors In Transmission And PathologyNational Institute Of Allergy And Infectious Diseases1995–1999
- Actg383--Dmp 266 In Combination With Nelfinavir In ChildrenNational Center For Research Resources1998
- Pediatric AIDS Clinical Trials Group--Coordinate/OperateNational Institute Of Allergy And Infectious Diseases1997–1998
- Actg179 Evaluation Of Ganciclovir For Congenital CytomegalovirusNational Center For Research Resources1997–1998
- Ctg254 Azithromycin &M-Atovaquone &Azithromycin-Bacterial Infection?D?D?D?D?D?National Center For Research Resources1997
- Actg152 Trial Of AZT VS DDI VS Azt/Ddi In HIV Infected ChildrenNational Center For Research Resources1997
- Salvage DDC For Symptomatic HIV Infected Children Failing DDI TherapyNational Center For Research Resources1996–1997
- Core--Primary Isolation And Specimen BankingNational Institute Of Allergy And Infectious Diseases1994–1997
- Actg240 Trial Of ZDV VS D4T In Children With HIV InfectionNational Center For Research Resources1996
- ACTG 245 Antiretroviral Therapy In Children With Advanced HIVNational Center For Research Resources1996
- Pediatric AIDS Clinical ResearchNational Institute Of Allergy And Infectious Diseases1994–1996
- Developmental Virology ResearchNational Institute Of Allergy And Infectious Diseases1994–1996
- Core--Virology LAB SupportNational Institute Of Allergy And Infectious Diseases1994–1996
- AIDS Clinical TrialsNational Institute Of Allergy And Infectious Diseases1994–1995
- Molecular Interaction Of HIV HCMVNational Institute Of Allergy And Infectious Diseases1989–1995
- Adult AIDS Clinical Trials UnitNational Institute Of Allergy And Infectious Diseases1992–1993
- AIDS Clinical Trials GroupNational Institute Of Allergy And Infectious Diseases1989–1991
- AIDS Clinical Trials Group (Conversion From Ateu)National Institute Of Allergy And Infectious Diseases1988
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: